GLP-1 & Metabolic

Retatrutide

SKU NA-069CAS 2381089-83-2MW 4731.3
99.1% HPLCThird-party testedRUO · Research use only
RUOThis product is sold for laboratory research use only. It is not a drug or supplement and is not for human or veterinary consumption, diagnostic or therapeutic use.

Price range: $27.00 through $112.99

HPLC verifiedPurity confirmed per lot
COA includedLot-specific certificate
Cold-chainShipped 2-8°C with packs
Lot traceableDocumented to dispatch
Description

Retatrutide is a triple-agonist research peptide (GIP, GLP-1 and glucagon receptors) provided as a lyophilized solid. Supplied with HPLC and mass-spec documentation for each production lot.

Specifications
CompoundRetatrutide
ClassificationTriple GIP/GLP-1/GCG agonist
CAS number2381089-83-2
Molecular formulaC221H342N46O68
Molecular weight4731.3 g/mol
Purity99.1% by RP-HPLC (area %)
Physical formLyophilized powder
AppearanceWhite solid
ReconstitutionBacteriostatic water, 0.6% acetic acid
Lab documentation

Each production lot is released against an analytical specification and ships with the corresponding Certificate of Analysis.

Certificate of AnalysisLot RET-2406-A
MethodRP-HPLC / UV 214 nm
Purity (area %)99.1%
IdentityESI-MS confirmed
AppearanceWhite solid
Storage & handling

Storage. Store lyophilized material at -20°C protected from light and moisture for long-term stability. After reconstitution, keep at 2-8°C and use within the documented in-use window.

Handling. Allow sealed vials to equilibrate to room temperature before opening to limit condensation. Reconstitute with the listed diluent using standard aseptic laboratory technique. Avoid repeated freeze-thaw cycles.

Safety. Handle as a laboratory research chemical. Wear appropriate PPE and follow your institution's chemical-handling and waste-disposal procedures.

Shipping

Dispatch. In-stock orders are processed on business days and shipped with temperature-controlled packaging and gel packs to preserve material integrity in transit.

Tracking. A tracking reference is issued at dispatch. Lab accounts can consolidate shipments and arrange standing orders.

Eligibility. Orders are accepted from researchers, resellers and institutions for laboratory research use only.

Selected research

Literature referencing this compound.

Publications relevant to this molecule, provided for research reference. Inclusion does not imply an approved use or any claim about the products sold here.

Phase 2 RCT
N Engl J Med. 2023;389(6):514–526
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
Jastreboff AM, Kaplan LM, Frías JP, et al.
Phase 2a RCT
Nat Med. 2024
Triple hormone-receptor agonist retatrutide for MASLD: a randomized phase 2a trial
Sanyal AJ, Kaplan LM, Frias JP, et al.